» Articles » PMID: 3023432

Establishment of Tac-negative, Interleukin-2-dependent Cytotoxic Cell Lines from Large Granular Lymphocytes (LGL) of Patients with Expanded LGL Populations

Overview
Journal J Clin Immunol
Publisher Springer
Date 1986 Nov 1
PMID 3023432
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Cell lines were established from purified large granular lymphocytes (LGL) isolated from the peripheral blood of seven patients with phenotypically homogeneous LGL expansions. LGL were stimulated with phytohemagglutinin (PHA) or recombinant interleukin-2 (rIL-2) and further expanded in vitro in IL-2-containing media. The surface phenotype of LGL, as assessed by monoclonal antibody staining, was T3+ T8+ in five patients, T3- T8- in one, and T3+ T8- in another patient. The cells also expressed Leu 7, Leu 11, and/or OKM 1 markers in various proportions and were identifiable as LGL by their morphological and cytochemical features. The original surface phenotype of the unstimulated LGL was retained in the IL-2-dependent cell lines from each individual patient, i.e., T3+ T8+ cells originated T3+ T8+ cell lines and T3- T8- cells originated T3- T8- cell lines. Other markers, such as Leu 11 and OKM 1, were generally lost in culture. LGL proliferated in response to rIL-2 but did not express detectable IL-2 receptors, even after prolonged periods of culture. All cell lines from each individual patient had the same surface phenotype, and within the single lines, all of the cells expressed the same markers. Cell lines from two patients consistently displayed chromosomal abnormalities. Although different in the two patients, the abnormalities were identical in all of the lines from the same patient and detectable in most of the cells examined, suggesting a clonal origin for the abnormally expanded LGL populations. Freshly isolated LGL did not exert NK activity. However, the IL-2-dependent LGL lines acquired the ability to kill K562 target cells and to produce gamma interferon (gamma-IFN). No direct correlation was observed between these two properties.

Citing Articles

Cytotoxic in vitro function in the lymphoproliferative disease of granular lymphocytes.

Zambello R, Chisesi T, Agostini C, Trentin L, Masciarelli M, Gasparotto G Clin Exp Immunol. 1987; 70(1):222-30.

PMID: 3121223 PMC: 1542199.


The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells.

Tsudo M, Goldman C, Bongiovanni K, Chan W, Winton E, Yagita M Proc Natl Acad Sci U S A. 1987; 84(15):5394-8.

PMID: 3110786 PMC: 298862. DOI: 10.1073/pnas.84.15.5394.


Serum levels of the low-affinity interleukin-2 receptor molecule (TAC) during IL-2 therapy reflect systemic lymphoid mass activation.

Voss S, Hank J, Nobis C, Fisch P, Sosman J, Sondel P Cancer Immunol Immunother. 1989; 29(4):261-9.

PMID: 2787694 PMC: 11037977. DOI: 10.1007/BF00199214.


Biology of natural killer cells.

Trinchieri G Adv Immunol. 1989; 47:187-376.

PMID: 2683611 PMC: 7131425. DOI: 10.1016/s0065-2776(08)60664-1.

References
1.
Aisenberg A, Krontiris T, Mak T, Wilkes B . Rearrangement of the gene for the beta chain of the T-cell receptor in T-cell chronic lymphocytic leukemia and related disorders. N Engl J Med. 1985; 313(9):529-33. DOI: 10.1056/NEJM198508293130901. View

2.
Linch D, Lipton J, Nathan D . Identification of three accessory cell populations in human bone marrow with erythroid burst-promoting properties. J Clin Invest. 1985; 75(4):1278-84. PMC: 425456. DOI: 10.1172/JCI111827. View

3.
van de Griend R, Bolhuis R . In vitro expansion and analysis of cloned cytotoxic T cells derived from patients with chronic T gamma lymphoproliferative disorders. Blood. 1985; 65(4):1002-9. View

4.
Rosenberg S . Lymphokine-activated killer cells: a new approach to immunotherapy of cancer. J Natl Cancer Inst. 1985; 75(4):595-603. View

5.
Fu S, Chiorazzi N, KUNKEL H . Differentiation capacity and other properties of the leukemic cells of chronic lymphocytic leukemia. Immunol Rev. 1979; 48:23-44. DOI: 10.1111/j.1600-065x.1979.tb00297.x. View